ARTICLE | Company News
Synthetic Biologics management update
October 29, 2012 7:00 AM UTC
Synthetic Biologics Inc. (NYSE-M:SYN), Ann Arbor, Mich. Business: Autoimmune, Neurology, Musculoskeletal Promoted: Michael Kaleko to SVP of R&D from scientific director ...